+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market by Type, Animal Type and Valence: Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 152 Pages
  • December 2021
  • Region: Bangladesh, India, Nepal, Sri Lanka
  • Allied Market Research
  • ID: 5548384
The India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market was valued at $127,107.12 thousand in 2020, and is estimated to reach $229,987.00 thousand by 2030, growing at a CAGR of 6.1% from 2021 to 2030.



Animal vaccines play a significant role in the protection of animal and public health, ensuring efficacy in the productivity of food animal sufficing the feed of ever-increasing human population. Animal vaccines have also reduced the risks posed by heavy dosage of antibiotics to food and companion animal. Veterinary vaccinations not only benefit animal health, but also have a major effect on the public health by aiding in elimination of zoonotic diseases, which transmit from animal to humans.

The growth of the India, Bangladesh, Sri Lanka, Nepal animal vaccine market is majorly driven by alarming increase in the prevalence of animal disease, such as Foot and Mouth Disease (FMD), Black Quarter (BQ), Newcastle disease, Infectious Bursal Disease, and Fowl Pox; rise in government initiative for development of various programs to vaccinate animals; surge in number of pet and poultry population; rise in expenditure on animal healthcare; and rise in adoption of animals. For instance, according to the World Organization of Animal Health (OIE), in 2018, it was reported that around 234,848 number of poultry animal are affected with Infectious Bursal Disease, in Nepal. Moreover, in June 2020, the National Centers for Disease control, in India, announced the National action plan in order to eliminate rabies from India, through “One Health” approach. Rise in number of animal vaccination camps and surge in demand for animal vaccine drive the growth of the market. For instance, in July 2019, Indian Immunological Limited (IIL), one of the leading biological companies, organize free animal vaccination camps across 170 centers in India. As per the same source, in July 2019, approximately 50,000 dose of anti-rabies vaccine (RAKSHARAB), manufactured by IIL, was administered in as many as 20 states through NGOs, and veterinary dispensaries. Thus, increase in the number of vaccine production and rise in prevalence of rabies are expected to propel the growth of the market.

Increase in the focus on animal safety and surge in demand for innovative pet care & medication are the major factors that drive the India, Bangladesh, Sri Lanka, Nepal animal vaccine market. Moreover, increase in demand for meat, egg and milk consumption significantly contributes toward the market growth. Rise in demand for veterinary care therapy for prevention of animal from infectious disease acts as a key driving force for the expansion of the animal vaccine market. Furthermore, rise in funds by government and private organizations to develop animal vaccination camps, and free vaccination programs are expected to boost the market growth. In addition, advancements in vaccine product, and surge in demand for pet insurance in emerging nations are anticipated to provide lucrative opportunities for the market expansion. For instance, in August 2020, the Bajaj Allianz General, one of the insurance policy company in India, announced the premium for pet dog insurance policy, which initiate from $3.15 million per annum.

However, high cost of milk, egg and meat prices, due to increase in cost of animal vaccine, and adverse effect of vaccines on animal and human health are anticipated to hinder the market growth. On the contrary, rise in disposable income, increase in animal healthcare spending, and increase in awareness among the population for management of animal vaccine schedule augment the growth of the India, Bangladesh, Sri Lanka, Nepal animal vaccine sector. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities in the India, Bangladesh, Sri Lanka, Nepal animal vaccine market.

The India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market is segmented on the basis of type, animal type, valence, and country. By therapy, the market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, recombinant vaccines, and DNA Vaccines. On the basis of animal type, it is categorized into companion animal, and poultry.

Depending on valence, it is bifurcated into monovalent, and multivalent. Country wise, it is analyzed across India, Bangladesh, Sri Lanka, and Nepal.

Some of the major companies that operate in the India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market are AniCon Labor Gmbh, Boehringer Ingelheim International GmbH, Cargill Animal Nutrition, Ceva Sante Animale, Hygieia Biological Laboratories, Intas Pharmaceutical Ltd., Merck KGAA, Romvac Company S.A, Sanofi, SavaVet, Vaxxinova Gmbh, Virbac S.A, Vivaldis, and Zoetis.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of the India, Bangladesh, Sri Lanka, Nepal animal vaccine market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the India, Bangladesh, Sri Lanka, Nepal animal vaccine market.

KEY MARKET SEGMENTS


By Type

  • Attenuated Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • DNA Vaccines

By Animal Type

  • Companion Animal
  • Dogs
  • Cats
  • Poultry

By Valence

  • Monovalent
  • Multivalent

By Country

  • India
  • Bangladesh
  • Sri Lanka
  • Nepal

KEY MARKET PLAYERS

  • AniCon Labor Gmbh
  • Boehringer Ingelheim International GmbH
  • Cargill Animal Nutrition
  • Ceva Sante Animale
  • Hygieia Biological Laboratories
  • Intas Pharmaceutical Ltd.
  • Merck KGAA
  • Romvac Company S.A
  • Sanofi
  • SavaVet
  • Vaxxinova Gmbh
  • Virbac S.A
  • Vivaldis
  • Zoetis
Frequently Asked Questions about the India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market

What is the estimated value of the India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market?

The India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market was estimated to be valued at $127107.12 thousand in 2020.

What is the growth rate of the India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market?

The growth rate of the India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market is 6.1%, with an estimated value of $229987 thousand by 2030.

What is the forecasted size of the India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market?

The India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market is estimated to be worth $229987 thousand by 2030.

Who are the key companies in the India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market?

Key companies in the India, Bangladesh, Sri Lanka, Nepal Animal Vaccine Market include Anicon Labor Gmbh, Boehringer Ingelheim International Gmbh, Cargill Animal Nutrition, Ceva Sante Animale, Hygieia Biological Laboratories, Intas Pharmaceutical Ltd, Merck Kgaa, Romvac Company S.A and Savavet.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in prevalence of disease in animal
3.5.1.2. Rise in animal healthcare expenditure
3.5.1.3. Increase in R&D activities for animal vaccine development
3.5.1.4. Growth in demand for pet insurance
3.5.2. Restraints
3.5.2.1. Highly competitive meat and milk prices
3.5.2.2. Adverse effect of veterinary vaccines on human and animal health
3.5.3. Opportunities
3.5.3.1. Advancement in vaccine products
3.5.3.2. Increase in demand for hybrid animal
3.5.4. Impact analysis
3.6. Impact analysis of COVID-19 on the India, Bangladesh, Sri Lanka, Nepal animal vaccine market
3.7. Pricing analysis
3.8. Per capital egg/meat consumption
3.9. Population of broilers/layers
3.10. Current vaccination coverage for different therapies
CHAPTER 4: INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Attenuated Vaccines
4.2.1. Key market trends, key growth factors and opportunities
4.2.2. Market size and forecast
4.3. Inactivated Vaccines
4.3.1. Key market trends, key growth factors and opportunities
4.3.2. Market size and forecast
4.4. Subunit Vaccines
4.4.1. Key market trends, key growth factors and opportunities
4.4.2. Market size and forecast
4.5. Toxoid Vaccines
4.5.1. Key market trends, key growth factors and opportunities
4.5.2. Market size and forecast
4.6. Recombinant Vaccines
4.6.1. Key market trends, key growth factors and opportunities
4.6.2. Market size and forecast
4.7. DNA Vaccines
4.7.1. Key market trends, key growth factors and opportunities
4.7.2. Market size and forecast
CHAPTER 5: INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY ANIMAL TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Companion animal
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast
5.2.3. Companion animal, by type
5.2.3.1. Market size and forecast
5.2.3.2. Dogs
5.2.3.2.1. Market size and forecast
5.2.3.3. Cats
5.2.3.3.1. Market size and forecast
5.3. Poultry
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast
CHAPTER 6: INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY VALENCE
6.1. Overview
6.1.1. Market size and forecast
6.2. Monovalent
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast
6.3. Multivalent
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast
CHAPTER 7: INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY COUNTRY
7.1. Overview
7.1.1. Market size and forecast
7.2. India
7.2.1. India animal vaccine market, by type
7.2.2. India animal vaccine market, by animal type
7.2.3. India animal vaccine market, by valence
7.3. Bangladesh
7.3.1. Bangladesh animal vaccine market, by type
7.3.2. Bangladesh animal vaccine market, by animal type
7.3.3. Bangladesh animal vaccine market, by valence
7.4. Sri Lanka
7.4.1. Sri Lanka animal vaccine market, by type
7.4.2. Sri Lanka animal vaccine market, by animal type
7.4.3. Sri Lanka animal vaccine market, by valence
7.5. Nepal
7.5.1. Nepal animal vaccine market, by type
7.5.2. Nepal animal vaccine market, by animal type
7.5.3. Nepal animal vaccine market, by valence
CHAPTER 8: COMPANY PROFILES
8.1. ANICON LABOR GMBH
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.2. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. CARGILL ANIMAL NUTRITION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.4. CEVA SANTE ANIMALE
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. HYGIEIA BIOLOGICAL LABORATORIES
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.6. INTAS PHARMACEUTICAL LTD
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.7. MERCK KGAA
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. ROMVAC COMPANY S.A
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.9. SANOFI
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. SAVAVET
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.11. VAXXINOVA GmbH
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Operating business segments
8.11.4. Product portfolio
8.12. VIRBAC S.A
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Operating business segments
8.12.4. Product portfolio
8.12.5. Business performance
8.13. VIVALDIS
8.13.1. Company overview
8.13.2. Company snapshot
8.13.3. Operating business segments
8.13.4. Product portfolio
8.14. ZOETIS
8.14.1. Company overview
8.14.2. Company snapshot
8.14.3. Operating business segments
8.14.4. Product portfolio
8.14.5. Business performance
List of Tables
TABLE 01. INDIA: ANIMAL VACCINES PRICES
TABLE 02. BANGLADESH: ANIMAL VACCINES PRICES
TABLE 03. SRI LANKA: ANIMAL VACCINES PRICES
TABLE 04. NEPAL: ANIMAL VACCINES PRICES
TABLE 05. PER CAPITAL EGG/MEAT CONSUMPTION (2020)
TABLE 06. NUMBER OF POPULATION OF BOILERS AND LAYERS CHICKENS (2019)
TABLE 07. VACCINE COVERAGE FOR DIFFERENT THERAPIES
TABLE 08. INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY TYPE, 2020-2030 ($THOUSANDS)
TABLE 09. INDIA ATTENUATED ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 10. INDIA INACTIVATED ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 11. INDIA SUBUNIT ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 12. INDIA TOXOID ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 13. INDIA RECOMBINANT ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 14. INDIA DNA ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 15. INDIA, BANGLADESH, SRI LANKA, NEPAL MARKET ANIMAL VACCINE MARKET, BY ANIMAL TYPE, 2020-2030 ($THOUSAND)
TABLE 16. INDIA COMPANION ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 17. COMPANION ANIMAL MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 18. VACCINATION FOR DOGS: CORE AND NON-CORE
TABLE 19. VACCINATION FOR CATS: CORE AND NON-CORE
TABLE 20. INDIA POULTRY ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 21. INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY VALENCE, 2020-2030 ($THOUSAND)
TABLE 22. INDIA MONOVALENT ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 23. INDIA MULTIVALENT ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 24. INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
TABLE 25. INDIA ANIMAL VACCINE TYPE MARKET, 2020-2030 ($THOUSAND)
TABLE 26. INDIA ANIMAL VACCINE MARKET FOR ANIMAL TYPE, 2020-2030 ($THOUSAND)
TABLE 27. INDIA ANIMAL VACCINE MARKET, BY VALENCE, 2020-2030 ($THOUSAND)
TABLE 28. BANGLADESH ANIMAL VACCINE MARKET, BY TYPE, 2020-2030 ($THOUSAND)
TABLE 29. BANGLADESH ANIMAL VACCINE MARKET FOR ANIMAL TYPE, 2020-2030 ($THOUSAND)
TABLE 30. BANGLADESH ANIMAL VACCINE MARKET, BY VALENCE, 2020-2030 ($THOUSAND)
TABLE 31. SRI LANKA ANIMAL TYPE VACCINE MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 32. SRI LANKA ANIMAL VACCINE MARKET FOR ANIMAL TYPE, 2020-2030 ($THOUSAND)
TABLE 33. SRI LANKA ANIMAL VACCINE MARKET FOR VALENCE, 2020-2030 ($MILLION)
TABLE 34. NEPAL ANIMAL TYPE VACCINE MARKET, 2020-2030 ($THOUSAND)
TABLE 35. NEPAL ANIMAL VACCINE MARKET FOR ANIMAL TYPE, 2020-2030 ($THOUSAND)
TABLE 36. NEPAL ANIMAL VACCINE MARKET, BY VALENCE, 2020-2030 ($THOUSAND)
TABLE 37. ANICON: COMPANY SNAPSHOT
TABLE 38. ANICON: OPERATING SEGMENT
TABLE 39. ANICON: PRODUCT PORTFOLIO
TABLE 40. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 41. BOEHRINGER INGELHEIM: OPERATING SEGMENT
TABLE 42. BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 43. BOEHRINGER INGELHEIM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 44. CARGILL: COMPANY SNAPSHOT
TABLE 45. CARGILL: OPERATING SEGMENT
TABLE 46. CARGILL: PRODUCT PORTFOLIO
TABLE 47. CEVA: COMPANY SNAPSHOT
TABLE 48. CEVA: OPERATING SEGMENT
TABLE 49. CEVA: PRODUCT PORTFOLIO
TABLE 50. CEVA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 51. HYGIEIA: COMPANY SNAPSHOT
TABLE 52. HYGIEIA: OPERATING SEGMENT
TABLE 53. HYGIEIA: PRODUCT PORTFOLIO
TABLE 54. INTAS: COMPANY SNAPSHOT
TABLE 55. INTAS: OPERATING SEGMENT
TABLE 56. INTAS: PRODUCT PORTFOLIO
TABLE 57. MERCK: COMPANY SNAPSHOT
TABLE 58. MERCK: OPERATING SEGMENTS
TABLE 59. MERCK: PRODUCT PORTFOLIO
TABLE 60. ROMVAC: COMPANY SNAPSHOT
TABLE 61. ROMVAC: PRODUCT PORTFOLIO
TABLE 62. SANOFI: COMPANY SNAPSHOT
TABLE 63. SANOFI: OPERATING SEGMENT
TABLE 64. SANOFI: PRODUCT PORTFOLIO
TABLE 65. SAVAVET: COMPANY SNAPSHOT
TABLE 66. SAVAVET: OPERATING SEGMENT
TABLE 67. SAVAVET: PRODUCT PORTFOLIO
TABLE 68. VAXXINOVA: COMPANY SNAPSHOT
TABLE 69. VAXXINOVA: OPERATING SEGMENT
TABLE 70. VAXXINOVA: PRODUCT PORTFOLIO
TABLE 71. VIRBAC: COMPANY SNAPSHOT
TABLE 72. VIRBAC: OPERATING SEGMENT
TABLE 73. VIRBAC: PRODUCT PORTFOLIO
TABLE 74. VIVALDIS: COMPANY SNAPSHOT
TABLE 75. VIVALDIS: OPERATING SEGMENT
TABLE 76. VIVALDIS: PRODUCT PORTFOLIO
TABLE 77. ZOETIS: COMPANY SNAPSHOT
TABLE 78. ZOETIS: OPERATING SEGMENT
TABLE 79. ZOETIS: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. INDIA, BANGLADESH, SRI LANKA, NEPAL ANIMAL VACCINE MARKET SEGMENTATION
FIGURE 02. TOP WINNING STRATEGIES, BY YEAR, 2019-2021
FIGURE 03. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
FIGURE 04. TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE BARGAINING POWER OF BUYERS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. HIGH THREAT OF NEW ENTRANTS
FIGURE 09. MODERATE INTENSITY OF RIVALRY
FIGURE 10. TOP PLAYER POSITIONING, 2020
FIGURE 11. IMPACT ANALYSIS
FIGURE 12. ANIMAL VACCINES MARKET FOR DOGS, 2020-2030 ($THOUSAND)
FIGURE 13. ANIMAL VACCINES MARKET FOR CATS, 2020-2030 ($THOUSAND)
FIGURE 14. BOEHRINGER INGELHEIM: NET SALES, 2018-2020 ($MILLION)
FIGURE 15. BOEHRINGER INGELHEIM: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 16. BOEHRINGER INGELHEIM: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 17. MERCK: NET SALES, 2018-2020 ($MILLION)
FIGURE 18. MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 19. MERCK: REVENUE SHARE BY REGION, 2020(%)
FIGURE 20. SANOFI: NET SALES, 2018-2020 ($MILLION)
FIGURE 21. SANOFI: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 22. SANOFI: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 23. VIRBAC: NET SALES, 2018-2020 ($MILLION)
FIGURE 24. VIRBAC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 25. VIRBAC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 26. ZOETIS: NET SALES, 2018-2020 ($MILLION)
FIGURE 27. ZOETIS: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 28. ZOETIS: REVENUE SHARE, BY REGION, 2020 (%)

Companies Mentioned

  • Anicon Labor Gmbh
  • Boehringer Ingelheim International Gmbh
  • Cargill Animal Nutrition
  • Ceva Sante Animale
  • Hygieia Biological Laboratories
  • Intas Pharmaceutical Ltd
  • Merck Kgaa
  • Romvac Company S.A
  • Sanofi
  • Savavet
  • Vaxxinova Gmbh
  • Virbac S.A
  • Vivaldis
  • Zoetis

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...